Title:
新規化合物
Document Type and Number:
Japanese Patent JP4589298
Kind Code:
B2
Abstract:
The invention relates to thienopyridazinones of formula (I): wherein: R1 is C1-6 alkyl, C2-6 alkenyl or C3-6 cycloalkyl which is optionally substituted by C1-6 alkyl, each of the above being optionally substituted by one or more halogen atoms; R2 is C1-6 alkyl; R3 is a group CO-G or SO2-G where G is a 5- or 6-membered ring containing a nitrogen atom and a second heteroatom selected from oxygen and sulphur adjacent to the nitrogen, and optionally substituted by up to 3 groups selected from hydroxyl and C1-4 alkyl; Q is CR5R6 where R5 and R6 are as defined in the specification; and R4 is a 5- to 10-membered mono- or bi-cyclic aromatic ring system, containing 0 to 4 heteroatoms independently selected from nitrogen, oxygen and sulphur, the ring system being optionally substituted as described in the specification, and pharmaceutically acceptable salts and solvates thereof. Processes for their preparation, pharmaceutical compositions containing them and their use in therapy, in particular in the modulation of autoimmune disease are also described.
Inventors:
Martin Edward Cooper
Simon David Guile
Anthony Howard Ingoal
Luxana Tasnieme Rasuru
Simon David Guile
Anthony Howard Ingoal
Luxana Tasnieme Rasuru
Application Number:
JP2006500749A
Publication Date:
December 01, 2010
Filing Date:
January 15, 2004
Export Citation:
Assignee:
ASTRAZENECA AKTIEBOLAG
International Classes:
C07D495/04; A61K31/50; A61K31/5025; A61K31/506; A61P11/00; A61P11/06; A61P11/08; A61P29/00; A61P37/06; C07D519/00; C07D
Domestic Patent References:
| JP2001525413A |
Attorney, Agent or Firm:
Aoyama Aoi
Mitsutaka Iwasaki
Shoji Nakajima
Mitsutaka Iwasaki
Shoji Nakajima